Date Initiated by Firm | November 30, 2015 |
Create Date | January 07, 2016 |
Recall Status1 |
Terminated 3 on October 30, 2016 |
Recall Number | Z-0607-2016 |
Recall Event ID |
72787 |
Product Classification |
System/device, pharmacy compounding - Product Code NEP
|
Product | Baxter CLEARLINK System, Blood Bag Spike Adapter, Luer Activated Valve for I.C. Access, 1C8687,
Product Usage:
C8687: An accessory to transfer a medicinal product from one container to another container. |
Code Information |
Lot Numbers: GR323907, GR324806, GR326116, GR326645, GR327528, and GR328534 |
Recalling Firm/ Manufacturer |
Baxter Healthcare Corp. 1 Baxter Pkwy Deerfield IL 60015-4625
|
For Additional Information Contact | Center for One Baxter 224-948-2000 |
Manufacturer Reason for Recall | Potential for dark loose particulate matter (400 microns or smaller) on the spike of the spike adapter or solution set. |
FDA Determined Cause 2 | Under Investigation by firm |
Action | Baxter sent an Urgent Product Recall letter by letter on 11/30/2015 to affected customers. The recall was extended to the consumer/user level. The letter instructed customers to locate and remove all affected product, contact Baxter Healthcare Center for Service to arrange for return of affected products and credit and complete the enclosed Baxter Customer Reply Form and return it to Baxter by either fax or scanned email. |
Quantity in Commerce | 77,136 units |
Distribution | US Nationwide Distribution and the country of Canada |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|